原发性肝癌淋巴结转移的治疗

摘要/Abstract

摘要： 原发性肝癌淋巴结转移是临床治疗的难点，其预后与局部晚期(IVA期) 肝癌相似，但现有文献并未给出肝脏区域淋巴结分类的准确定义，亦缺乏不同部位淋巴结转移的临床资料。手术治疗肝癌淋巴结转移仍存在争议，手术技术的进步使手术安全性得到保障，可以使部分患者生存期受益，预防性淋巴结清扫可以切除影像学检查难以发现的微转移灶，但迄今未发现具有指导意义的转移相关的标记物。右半肝肝癌的区域淋巴结清扫范围主要包括切除肝十二指肠韧带、胰腺后方区域、肝总动脉旁淋巴结直到腹腔干淋巴结。左半肝肝癌需要重点清扫胃左动脉淋巴结及网膜囊淋巴结。肝癌淋巴结转移对放疗敏感，放疗剂量应控制在56Gy以内。射频消融、通过经皮经肝的淋巴系统造影术局部化疗、免疫治疗等是可以选择的综合治疗方法。

关键词: 原发性肝癌, 淋巴结转移, 治疗

Abstract: The treatment of primary liver cancer accompaning with lymph node metastasis is still one of the most challenge clinic task.It has similar prognosis with locally advanced hepatocellular carcinoma(IVA).The exact definition of regional lymph nodes related to liver is not provided in ready literatures.The clinical data of different lymph node metastasis is poor.The surgical treatment of liver cancer accompaning with lymph node metastasis is still controversial.Although survival time of some patients was able to benefit from resection without more mortality and modality,the prophylactic lymph node dissection may remove micrometastases of lymph nodes which can’t be detected through preoperative imaging examination.No critical tumor marker related to lymph node metastasis is found so far.The extent of regional lymphadenectomy to right lobe hepatic cancer should include hepatoduodenal ligament,peripancreatic,periportal,along the common hepatic artery and celiac lymph nodes.As to left lobe hepatic cancer,left gastric artery and omental sac lymph nodes should be dissected.The lymph node metastasis from liver cancer is sensitive to radiotherapy so the dose should be controlled within 56Gy.Radiofrequency ablation,local chemotherapy with percutaneous transhepatic lymphography and immunotherapy are some alternative therapies.

Key words: Primary liver cancer, Lymph node metastasis, Therapy

中图分类号:

R605

王健东. 原发性肝癌淋巴结转移的治疗[J]. 外科研究与新技术, 2013, 2(3): 145-148.

WANG Jian-dong. Combined therapy of primary liver cancer with lymph node metastasis[J]. Surgical Research and New Technique, 2013, 2(3): 145-148.

参考文献

[1]Ahmedin J,Freddie B,Melissa M,et al.Global Cancer Statistics [J].CA Cancer J Clin,2011,61(2):69-90.
[2] 中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志,2009,14(3):259-263.
[3] Hasegawa K,Makuuchi M,Kokudo N,et al.Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma:report of a Japanese nationwide survey [J].Ann Surg,2013 Mar 25.
[4] Lee CW,Chan KM,Lee CF,et al.Hepatic resection for hepatocellular carcinoma with lymph node metastasis:clinicopathological analysis and survival outcome [J].Asian J Surg,2011,34(2):53-62.
[5] Xiaohong S,Huikai L,Feng W,et al.Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma [J].World J Surg,2010,34(5):1028-1033.
[6] Kobayashi S,Takahashi S,Kato Y,et al.Surgical treatment of lymph node metastases from hepatocellular carcinoma [J].J Hepatobiliary Pancreat Sci,2011,18(4):559-566.
[7] Shimada S,Yamashita Y,Aishima S,et al.Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma [J].Br J Surg,2001,88(11):1463-1466.
[8] Sun HC,Zhuang PY,Qin LX,et al.Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy [J].J Surg Oncol,2007,96(1):37-45.
[9] Grobmyer SR,Want L,Gonen M,et al.Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy [J].Ann Surg,2006,244(2):260-264.
[10] Ercolani G,Grazi GL,Ravaioli M,et al.The role of lymphadenectomy for liver tumors:further considerations on the appropriateness of treatment strategy [J].Ann Surg,2004,239(2):202-209.
[11] Mima K,Masuda T,Beppu T,et al.A long-term survival case of hepatocellular carcinoma with lymph node metastases treated with surgery and radiotherapy [J].Gan To Kagaku Ryoho,2008,35(12):2096-2098.
[12] Togo S,Takahashi T,Tanaka K,et al.Long-term survival in a patient with hepatocellular carcinoma with resection of a metastatic lymph node after percutaneous ethanol injection therapy [J].Int J Clin Oncol,2004,9(5):393-397.
[13] Utsumi M,Matsuda H,Sadamori H,et al.Resection of Metachronous Lymph Node Metastases from Hepatocellular Carcinoma after Hepatectomy:Report of Four Cases [J].Acta Med Okayama,2012,66(2):177-182.
[14] Hashimoto M,Matsuda M,Watanabe G.Metachronous resection of metastatic lymph nodes in patients with hepatocellular carcinoma [J].Hepatogastroenterology,2009,56(91-92):788-792.
[15] Ravaioli M,Ercolani G,Luca G,et al.Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors [J].Updates Surg,2010,62(1):27-34.
[16] Zeng ZC,Tang ZY,Yang BH,et al.Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma,phase I clinical trial [J].Hepatogastroenterology,2004,51(55):201-207.
[17] Gao F,Gu Y,Huang J,et al.Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes from Hepatocellular Carcinoma [J].Acad Radiol,2012,19(8):1035-1040.
[18] Teramoto K,Kawamura T,Okamoto H,et al.Percutaneous transhepatic lymphography method to image and treat intra-abdominal lymph node metastasis in patients with unresectable hepatobiliary pancreatic cancer [J].Surgery,2002,131(5):529-533.